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A B S T R A C T   
Objectives: In multiple sclerosis (MS), the presence of a paramagnetic rim at the edge of non-gadolinium-en-
hancing lesions indicates perilesional chronic inflammation. Patients featuring a higher paramagnetic rim lesion 
burden tend to have more aggressive disease. The objective of this study was to develop and evaluate a con-
volutional neural network (CNN) architecture (RimNet) for automated detection of paramagnetic rim lesions in 
MS employing multiple magnetic resonance (MR) imaging contrasts. 
Materials and methods: Imaging data were acquired at 3 Tesla on three different scanners from two different 
centers, totaling 124 MS patients, and studied retrospectively. Paramagnetic rim lesion detection was in-
dependently assessed by two expert raters on T2*-phase images, yielding 462 rim-positive (rim+) and 4857 rim- 
negative (rim-) lesions. RimNet was designed using 3D patches centered on candidate lesions in 3D-EPI phase 
and 3D FLAIR as input to two network branches. The interconnection of branches at both the first network blocks 
and the last fully connected layers favors the extraction of low and high-level multimodal features, respectively. 
RimNet’s performance was quantitatively evaluated against experts’ evaluation from both lesion-wise and pa-
tient-wise perspectives. For the latter, patients were categorized based on a clinically relevant threshold of 4 rim 
+ lesions per patient. The individual prediction capabilities of the images were also explored and compared 
(DeLong test) by testing a CNN trained with one image as input (unimodal). 
Results: The unimodal exploration showed the superior performance of 3D-EPI phase and 3D-EPI magnitude 
images in the rim+/- classification task (AUC = 0.913 and 0.901), compared to the 3D FLAIR (AUC = 0.855, 
Ps  <  0.0001). The proposed multimodal RimNet prototype clearly outperformed the best unimodal approach 
(AUC = 0.943, P  <  0.0001). The sensitivity and specificity achieved by RimNet (70.6% and 94.9%, respec-
tively) are comparable to those of experts at the lesion level. In the patient-wise analysis, RimNet performed with 
an accuracy of 89.5% and a Dice coefficient (or F1 score) of 83.5%. 
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Conclusions: The proposed prototype showed promising performance, supporting the usage of RimNet for 
speeding up and standardizing the paramagnetic rim lesions analysis in MS.   
1. Introduction 
Multiple sclerosis (MS) is an immune-mediated disorder character-
ized by focal inflammatory and demyelinating lesions in the brain and 
spinal cord. After acute inflammatory demyelination subsides, com-
partmentalized/smoldering inflammation persists at the edge of some 
chronic MS lesions, termed “chronic active lesions.” These lesions, 
which are pathologically characterized by perilesional accumulation of 
iron-laden microglia/macrophages (Absinta et al., 2016; Dal-Bianco 
et al., 2017; Kaunzner et al., 2019), can be depicted with in vivo sus-
ceptibility-based MRI as non-gadolinium enhancing lesions with a 
paramagnetic rim (see Fig. 1A) (Hammond et al., 2008; Pitt et al., 2010; 
Bagnato et al., 2011; Hagemeier et al., 2012; Yao et al., 2012; Walsh 
et al., 2013; Wisnieff et al., 2015; Harrison et al., 2016; Dal-Bianco 
et al., 2017; Absinta et al., 2018; Kaunzner et al., 2019). From a clinical 
perspective, accrual of MS patient’s disability despite available disease 
modifying therapies is associated with a higher paramagnetic rim lesion 
burden (Harrison et al., 2016; Absinta et al., 2019). So far, routine 
imaging protocols can only detect MS acutely inflamed gadolinium- 
enhancing lesions, and no tools are available to depict chronically in-
flamed lesions. Moreover, in progressive MS patients, conventional 
radiological markers of disease activity (such as new T2 lesions or ga-
dolinium-enhancing lesions) are rarely detectable. For all these reasons, 
the paramagnetic rim MRI biomarker might be used for patient strati-
fication and potentially serve as an outcome measure in MRI based 
clinical trials in the future ( Absinta et al., 2019). 
Imaging protocols for the paramagnetic rim analysis usually include 
a T2-weighted sequence (such as 3D FLAIR (Chagla et al., 2008)) for 
lesion detection and a susceptibility-based sequence (such as T2*- 
weighted, T2*-w, magnitude and phase, susceptibility-weighted ima-
ging, or quantitative susceptibility mapping) to classify lesions based on 
whether a paramagnetic rim is visible or not (Hagemeier et al., 2012; 
Yao et al., 2012; Absinta et al., 2018; Kaunzner et al., 2019). Up to the 
present time, the presence/absence of perilesional paramagnetic rims 
has been determined through visual inspection by experts. 
A robust and accurate method to automatically detect paramagnetic 
rim lesions would represent a valuable decision support tool for radi-
ologists and an opportunity to facilitate integration of this promising 
MRI biomarker into the MS clinical reading workflow. Moreover, given 
the interobserver variability observed for this particular task (Absinta 
et al., 2018), the integration of such method as a potential CNN second 
rater, would help to yield more reliable paramagnetic rim lesions as-
sessment. To our knowledge, such an approach has not yet been ex-
plored. From a computer vision perspective, the classification of lesions 
based on the presence/absence of a paramagnetic rim faces three major 
challenges: 1) the intensity features of the rim are not necessarily dis-
cernible from the internal lesion parenchyma and/or surrounding white 
matter (WM) tissue (Fig. 1C); 2) some rim-like intensity artefacts may 
appear (Fig. 1D); and 3) the scarcity of paramagnetic rim lesions for 
training due to their relatively lower frequency in MS patients (im-
balanced dataset with a large majority of non-paramagnetic rim le-
sions). 
In this work, we propose the first automated method based on su-
pervised classification to distinguish lesions featuring a paramagnetic 
rim (hereafter referred as rim+ or rim-). Our method is based on a 3D 
patch-based convolutional neural network (CNN) architecture 
(RimNet), which exploits different MR imaging contrasts combined at 
the first and last layers of the network. We have performed a multi- 
center and multi-scanner comparison of our CNN results and evaluated 
the performance (at both the lesion and patient level) in comparison to 
the manual annotation of two experts on a cohort of 124 MS patients. 
2. Materials and methods 
2.1. Participants and MRI acquisition 
We retrospectively analyzed MRI scans from MS patients diagnosed 
according to the revised 2010 McDonald MS criteria (Polman et al., 
2011) who were recruited between December 2017 and September 
2019 in two academic research hospitals, the Centre Hospitalier Uni-
versitaire Vaudois (Lausanne, Switzerland) and the Universitätsspital 
Basel (Basel, Switzerland). Of the 141 eligible MS patients, 124 were 
included (11 patients were excluded because of motion artefacts and 6 
because of coexisting brain pathologies): 55 patients (33 female, 
25–76 years old) in Lausanne and 69 patients (44 female, 22–73 years 
old) in Basel. Patients' demographic and clinical characteristics are 
summarized in Table 1. The study received approval by the local ethics 
committee, and all patients gave written informed consent for the 
Fig. 1. Example of MS lesions on 3D FLAIR (left), 3D-EPI magnitude (center) and phase (right) images. A) and B) are clear examples of lesions with presence (rim+) 
and absence (rim-) of a paramagnetic rim, respectively. In C) there are two more subtle rim+ lesions. D) is an example of a rim- lesion that has a rim+ like intensity 
artefact. 
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retrospective use of their data. 
All patients underwent a single brain MRI acquisition at 3T (either 
MAGNETOM Skyra or MAGNETOM Prisma, Siemens Healthcare, 
Erlangen, Germany) in Lausanne; MRI in Basel were also acquired at 3T 
(MAGNETOM Prisma, Siemens Healthcare, Erlangen, Germany). In 
both centers, three-dimensional segmented echo-planar imaging (3D- 
EPI) (Sati et al., 2014), giving high-resolution T2*-w magnitude and 
phase images, and 3D T2-FLAIR images were acquired (Table 2). A 3D 
T1-weighted MPRAGE sequence was acquired in Lausanne and a 3D 
MP2RAGE in Basel (Marques et al., 2010). 3D-EPI images were ob-
tained with a resolution of 0.65x0.65x0.65 mm3 and 
0.67x0.67x0.67 mm3 in Lausanne and Basel hospitals, respectively. 3D 
FLAIR, MPRAGE, and MP2RAGE images were acquired with an iso-
tropic resolution of 1 mm in both centers. 
2.2. Preprocessing steps 
Three-dimensional MPRAGE or MP2RAGE were rigidly registered to 
the FLAIR space. Automated lesion segmentation was performed using a 
recently proposed deep learning architecture (La Rosa et al., 2020) which 
uses FLAIR and MP2RAGE to segment white matter and cortical lesions. 
In order to generate the lesion segmentation of those patients without the 
MP2RAGE available, the same network was re-trained with MPRAGE 
instead. For MPRAGE cases, segmentations were evaluated visually. 
The post-processing and registration of unwrapped phase images 
were performed as previously described (Chavhan et al., 2009; Absinta 
et al., 2013). Three-dimensional (3D) FLAIR images, along with the 
lesion segmentations, were affinely registered to the T2* 3D-EPI space. 
Also, anatomical segmentations were generated with FreeSurfer (Fischl 
et al., 2002; Fujimoto et al., 2014) from MPRAGE or MP2RAGE images 
and affinely registered to the T2* 3D-EPI space. Lesion holes were filled 
with the lesion-filling function included in the FSL package (Battaglini, 
Jenkinson, and De Stefano 2012). All registrations were performed with 
the SimpleElastix tools (Marstal et al., 2016) by using the adaptive 
stochastic gradient descent optimizer together with the advanced 
Mattes mutual information metric (Mattes et al., 2001). The T2*-w 3D- 
EPI magnitude, the unwrapped 3D-EPI phase and the 3D FLAIR images 
will be hereafter referred as T2*, phase, and FLAIR, respectively. 
2.3. Annotations of paramagnetic rim lesions 
For training and evaluation of our deep-learning supervised classi-
fication method, a ground truth sample of rim+ and rim- was obtained 
(Yao et al., 2012). Rim+ lesions were manually annotated by two 
raters (PM and MA, with imaging research experience of 10 and 
14 years, respectively), as summarized in Fig. 2A. For exploring the 
presence of rims, the phase images were primarily used, which helped 
to identify the phase shift mainly produced by iron-laden macrophages 
and relative myelin content at the lesion edge ( Absinta et al., 2016; 
Dal-Bianco et al., 2017). Moreover, 3D FLAIR was used in the annota-
tion process to visually assess whether paramagnetic rims identified on 
the phase images matched an MS lesion on FLAIR, which allowed dis-
carding potential false positives due to rim-shaped artefacts. After a first 
screening conducted individually by each expert, 38.3% of the lesions 
needed consensus review (Kappa score of 0.73 (Viera and Garrett 
2005)), which was done in a second joint screening by the two experts. 
After consensus, 462 rim+ lesions were identified and further used in 
our study as the ground truth. The distribution of rim+ lesions per 
patient is shown in Fig. 3. 
Rim- lesions were annotated as follows. Each connected component 
in the segmentation output (corresponding to the connected compo-
nents by considering a 6-connected-voxels neighborhood) was con-
sidered a lesion candidate. All lesions that did not overlap with the 
rim + map were labeled as rim-. In order to have one lesion candidate 
paired with only one experts’ rim+ annotation, an experienced tech-
nician manually separated the rim+ lesions inside confluent ones. 
A volume analysis performed with the lesions’ automatic segmen-
tations revealed that all rim+ lesions included in our dataset were 
bigger than 12.3 mm3. As a result, we decided to exclude lesions 
smaller than 12.3 mm3 (1671 rim- lesions) from our study, as such 
small lesions could systematically be classified as rim- lesions. 
Interestingly, the volume analysis showed that rim+ lesions were, in 
general, bigger (325.2  ±  410.5 mm3) than rim- lesions 
(102.6  ±  231.8 mm3). However, these values must be cautiously in-
terpreted as they were computed without manual corrections to better 
fit lesion borders, so real volumes could slightly differ. 
Overall, our dataset of 124 patients contains 4857 rim- and 462 rim 
+ annotated lesions (10.5:1 ratio). 
2.4. Patch extraction 
Our motivation for a patch-based approach was based on two key 
factors. First, the experts’ decision relied exclusively on the appearance of 
the lesions and their close surroundings. Second, a patch-based approach 
allowed us to effectively deal with the class imbalance problem. As a 
counterpart, such an approach entails the extra challenge of choosing a 
suitable patch size. In our case, this patch needed to be big enough to cover 
most lesions while including only one lesion insofar as possible. We 
Table 1 
Number of patients per hospital, mean and standard deviation of patients’ age, median and interquartile range of patients’ EDSS (Kurtzke 1983) and number of 
patients per MS type. Abbreviations: EDSS, expanded disability status scale; RRMS, relapsing-remitting MS; PPMS, primary-progressive MS; SPMS, secondary- 
progressive MS.          
Hospital Scanner #Patients Age (years) EDSS RRMS PPMS SPMS  
Lausanne Skyra/Prisma 55 47.8  ±  11.0 2.0 (1.5–5.0) 36 9 10  
Skyra 28 48.5  ±  10.9 2.8 (1.5–4.9) 18 5 5  
Prisma 27 47.0  ±  11.3 2.0 (1.5–5.0) 18 4 5 
Basel Prisma 69 42.0  ±  14.1 2.5 (1.5–4.0) 51 7 11 
Total  124 45.0  ±  13.1 2.0 (1.5–4.5) 87 16 21 
Table 2 
Parameters of the MRI acquisition protocol followed in each center.     
Hospital Lausanne Basel  
Magnet strength 3T 3T 
Manufacturer Siemens Siemens 
Model Prisma/Skyra Prisma 








0.65 1 0.67 1 
N° of slices 288 176 256 176 
Repetition time (TR, ms) 64 5000 64 5000 
Echo time (TE, ms) 35 391 35 386 
Inversion time (TI, ms) – 1800 – – 
Flip angle (deg) 10 Variable 10 Variable 
Averages 1 1 1 1 
Acquisition time 6′ 20″ 4′ 47″ 6′ 19″ 5′ 40″ 
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experimentally found out that a patch of size 28x28x28 voxels represented 
a good trade-off between both requirements. With a cube of such size, we 
managed to cover the 90% of the rim+ lesions at their full extent. 
Hence, image patches were extracted centered on the center of mass 
of the automatically detected lesions and linearly normalized between 
−1 and 1 (Maggi et al., 2020). To ensure that the model was trained 
with reliable patches, we automatically removed lesions according to 
the following exclusion criteria. First, to make sure the whole rim was 
contained within the patch, lesions over 10,000 voxels were removed 
(32 rim- and 4 rim+ lesions). Lesions near air artefacts (discernible in 
phase) were also excluded (25 rim- and 1 rim+ lesions). Finally, to 
ensure that rim- patches did not also contain rim+ lesions, rim- patches 
with more than 900 voxels (410.5 mm3) belonging to rim+ lesions 
were removed (113 rim- lesions). The latter threshold was chosen 
considering the average volume of rim+ lesions. Thus, our training set 
included 4687 rim- and 457 rim+ lesions (10.3:1 ratio). 
2.5. Network architecture 
Our multimodal framework for the classification of rim+/rim- lesions 
is inspired by the expert’s imaging setting, which consists in the visual 
inspection of phase and FLAIR images. In this way, the prototype RimNet, 
see Fig. 4, is built upon two parallel CNNs based on the Visual Geometry 
Group Net (VGGNet) (Simonyan and Zisserman, 2015), which has proven 
Fig. 2. Description of the protocol used to label and generate our dataset. A) For each patient, two experts visually inspected the 3D-EPI phase and 3D FLAIR images 
and only reported paramagnetic rim lesions (rim+ lesions). The rim+ lesions detected by one expert and undetected or considered rim- by the other (unreported) 
went through a joint session where experts provided a final decision. B) Lesion candidates were extracted from the automatic segmentation (corresponding to the 
connected components by considering a 6-connected-voxels neighborhood) and matched with the rim+ annotations. In order to guarantee that one lesion candidate 
matched only one rim+ lesion annotation, a technician manually separated the rim+ lesions inside confluent ones. (1) MP2RAGE for Basel patients and MPRAGE for 
Lausanne patients. 
Fig. 3. Distribution of patients according to their number of paramagnetic rim 
lesions (rim + lesions) in Lausanne and in Basel. The number (N°) of patients 
with 0, 1–3 and ≥ 4 paramagnetic rim lesions are reported for both Lausanne 
(scale of blue) and Basel (scale of green). (For interpretation of the references to 
colour in this figure legend, the reader is referred to the web version of this 
article.) 
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to outperform other state-of-the-art architectures in similar multimodal 
approaches (Le et al., 2017). Each single CNN, or branch, receives a patch 
and feeds it to a succession of three blocks of two convolutional layers 
followed by a max-pooling layer. The main branch extracts phase fea-
tures, which are merged with those extracted from FLAIR after the very 
first block in order to exploit multimodal low-level features. Finally, the 
two four-dimensional output tensors of each CNN are concatenated before 
being fed to a final succession of fully connected layers, which profits 
from the high-level multimodal features. 
Phase features were needed as they better depict the presence/ab-
sence of paramagnetic rim. Additionally, we hypothesized that 1) 
FLAIR, with its optimal lesion-WM contrast, would provide lesion’s 
morphometric and location-aware features that could help in the rim 
+/- classification task; and 2) T2* could help in detecting rims with 
high paramagnetic effect. In order to validate these hypotheses, alter-
native RimNet configurations were also tested and compared: 1) re-
placing FLAIR by T2* (phase + T2*) and 2) using T2* instead of phase 
(T2* + FLAIR). 
Along with the proposed multimodal scenarios, we also evaluated 
the prediction capability of each contrast separately and used these as 
baseline models. For this unimodal exploration, we used a network 
consisting of only one CNN branch of the RimNet directly connected to 
the cascade of fully connected layers. 
2.6. Training strategy 
Data augmentation is a well-known strategy for training deep neural 
networks to increase the performance in the testing phase. It is also a good 
strategy to tackle the class imbalance problem. Our preprocessed data 
augmentation consisted in rotating each rim+ lesion by 90°, 180°, and 
270° in the three axes, which led to a tenfold increase of rim + and a 
1.03:1 class ratio in the training set. Moreover, three elastically deformed 
versions of each lesion were generated, effectively quadrupling the training 
data. We also performed online data augmentation during the training first 
by flipping the patch along an axis (X, Y, Z, or none) and then by 
translating it 2 voxels (−2, 0 or +2) towards each of the three possible 
axes (X, Y, and Z). Both processes were designed to avoid generating re-
peated patches and hence increase the generalization of our model. 
In order to avoid overfitting and to better reflect the performance in 
a clinical scenario, models were trained following a per-site stratified 
four-fold nested cross-validation procedure. The stratification process 
took into consideration the number of samples per class (rim+/-) and 
per center included in each fold. To perform a patient-wise rim analysis 
simulating a real case scenario, we imposed that all lesions of the same 
patient had to belong to the same split. This yielded folds each with 
36.3  ±  1.9 and 78.0  ±  0.0 rim+ lesions (492.8  ±  4.6 and 
679.0  ±  4.9 rim- lesions) from Lausanne and Basel, respectively. 
Regarding the number of patients, each fold contained 13.8  ±  0.8 
from Lausanne and 17.2  ±  3.0 from Basel. All experiments were 
trained with this fold configuration. 
In RimNet, each branch was trained with its own weights. The 
training of our models was conducted as follows: the initial weights were 
drawn from Xavier initialization (Glorot and Bengio, 2010), a hyperbolic 
tangent (tanh) was used as activation function, batch normalization was 
applied, and loss minimization was performed by the ADAM optimizer 
(Kingma and Ba, 2017), along with learning rate decay and early stop-
ping. For each fold’s distribution, a three-fold inner cross-validation de-
termined the number of epochs trained with each learning rate 
(1.0·10 , 5.0·10 , 2.5·10 , 1.0·104 5 5 5) before its decay, which was trig-
gered after three consecutive epochs without a decrease in the validation 
loss. Early stopping was applied when the last learning rate change was 
triggered. For all network configurations, training was done with a batch 
size of 32 and SoftMax cross-entropy as the loss function. 
In order to evaluate the generalization of RimNet across different 
clinical centers, we additionally performed an inter-scanner/hospital 
study where the network was trained with only the Basel patients and 
then tested on the Lausanne dataset. The cross-validation process 
yielded four models trained with Basel data, which were used as an 
ensemble of classifiers to infer the labels for Lausanne patients’ lesions. 
Fig. 4. The architecture of RimNet. Built upon two parallel CNNs inspired by VGGNet, the proposed RimNet favors the multimodal low-level feature extraction by 
merging the output of the first convolutional block (two convolutions followed by a max pooling) of the second image to that of the main image (3D FLAIR and 3D- 
EPI phase in the figure, respectively). Finally, high-level multimodal feature maps are exploited through the final cascade of fully connected layers. Abbreviations: 
tanh, hyperbolic tangent function. 
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2.7. Statistical evaluation 
Receiver operating and precision-recall curves (ROC and PR, re-
spectively) of the different testing folds were interpolated (piecewise 
constant interpolation) and averaged to show the overall performance 
at the lesion-level of the trained network configurations. For each 
curve, the area under the curve value (AUC) was computed by aver-
aging the four AUC values across the testing folds. A comparison of ROC 
curves among different network configurations was carried out using 
the DeLong test (DeLong, DeLong, and Clarke-Pearson, 1988), using the 
implementation included in the pROC package in R (“R-Project, Version 
3.6.2.” n.d.) (Robin et al., 2011). 
A patient-level analysis was also performed. The performance of the 
experts was evaluated by comparing their individual pre-consensus 
annotations with the ground truth. To do so, we set the operating point 
so it yielded a specificity of 95%, and we categorized patients as 
“chronic active” and “non-chronic active” based on the total number of 
rim + lesions per patients, following a previous study that observed 
higher disability in patients with four lesions or more than those with 
fewer ( Absinta et al., 2019; Maggi, 2020). 
In both lesion- and patient-wise analysis, sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (PPV) 
were calculated from the confusion matrices and compared using the 
McNemar test with continuity correction. P-value  <  0.05 was con-
sidered statistically significant. 
2.8. Error analysis 
The lack of established international consensus criteria on the rim+/- 
classification problem leads to low inter-rater reliability. A disagreement 
between both raters prior to consensus could be interpreted as a low- 
confidence indicator of their joint decision. To understand the challenges 
that these ambiguous lesions posed to our method, we divided our lesions 
into two subsets based on the existence or not of an initial agreement on 
both raters’ decision and compared the performance of RimNet 
(phase + FLAIR) on both. The comparison was done by using the in-
dependent samples T-test without assuming equal variance. 
Additionally, a second rating was carried out for the lesions mis-
classified by RimNet with a certainty value over 95%, according to the 
probability inferred by the network’s last layer. To do so, experts 
worked blinded to each other but knew both the current ground truth 
label and the prediction of RimNet. After this independent re-evalua-
tion, experts reached consensus during a joint session for the lesions 
where they had initially disagreed. RimNet errors were classified into: 
1) true network mistakes, 2) ground truth mistakes (lesions missed by 
the experts or where experts changed their rating based on RimNet’s 
decision) and 3) incorrect candidate lesion selection, specifically rim- 
lesions that, according to experts, should not be considered as such due 
to confluence with rim+ lesions. 
Finally, anatomical segmentations were used to analyze the per-
formance of RimNet depending on lesion location. Five patients were 
excluded from this analysis because of segmentation or registration 
issues. The regions-of-interest included were cerebrum deep white 
matter, cortex, ventricles, deep gray matter, brainstem and cerebellum. 
The cortex and the ventricles were dilated by 2 mm and 3 mm, re-
spectively, according to previous definitions of periventricular and 
juxtacortical MS lesions (Jehna et al., 2015; Filippi, Preziosa, and 
Rocca, 2019). An overlap of at least half of the lesion’s volume with a 
region of interest was required to categorize the lesion as belonging to 
that respective region except for the periventricular white matter, 
where any overlap was considered. The classification performance of 
RimNet was evaluated in each region. 
3. Results 
3.1. Lesion-wise analysis 
Results of the lesion-wise analysis for all single and multimodal 
tested architectures are shown in Fig. 5. The prior exploration of the 
prediction capabilities of each individual modality shows that all 
modalities can, with different contributions, predict rim + lesions 
substantially better than chance. As expected, both susceptibility-based 
modalities performed better than FLAIR (AUC = 0.855) at classifying 
rim+ lesions (P's  <  0.0001). Thus, phase (AUC = 0.913) and T2* 
(AUC = 0.901) position themselves as the best sequences for this task 
(P = 0.47, DeLong test). 
The prototype RimNet was evaluated with three different combi-
nations of modalities as input: phase + FLAIR (AUC = 0.946), 
phase + T2* (AUC = 0.943), and T2* + FLAIR (AUC = 0.926). All 
combinations clearly outperformed the best unimodal architecture (P 
values of  <  0.0001, < 0.0001, and 0.0183, respectively). At the same 
time, bimodal combinations of phase and either T2* or FLAIR showed 
significantly higher prediction capabilities than the T2* and FLAIR 
combination (P values of 0.003 and 0.023, respectively). No statistically 
significant differences were found between phase + T2* and 
phase + FLAIR (P = 0.48), so hereafter we will call the proposed 
network with the latter inputs’ configuration RimNet. In the inter- 
center study evaluation (Fig. 6), RimNet trained only with Basel sam-
ples showed a performance (AUC = 0.953) indistinguishable from the 
same network configuration trained with samples from both centers 
Fig. 5. ROC and PR curves for all network configurations. Abbreviations: ROC, receiver operating characteristic; PR, precision-recall; ICS, inter-center study; Single, 
unimodal network; RimNet, the proposed multimodal network. 
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(AUC = 0.958, P = 0.47). 
The lesion-wise performance metrics of the best single architecture 
(phase) and RimNet were computed on the specified operating point 
and compared to experts in Table 3. Results for the inter-center study 
are also included. For the cross-validation configuration, the single 
modality model performed with a sensitivity of 62.1%, a specificity of 
95.0%, a PPV of 53.9%, and an NPV of 96.3%, while RimNet performed 
with a sensitivity of 70.6%, a specificity of 94.9%, a PPV of 56.9%, and 
an NPV of 97.1%. In the inter-center study, RimNet performed with a 
sensitivity of 75.8%, a specificity of 95.1%, a PPV of 52.8%, and an NPV 
of 98.3%. In both scenarios, lesion-wise performance for both raters 
was superior to the one of the evaluated models (McNemar’s test; 
P’s  <  0.0001). 
3.2. Patient-wise analysis 
We evaluated the RimNet patient classification performance based on 
the number of rim + lesions per patient. To do so, we kept the operating 
point at a lesion-wise accepted false positive rate (FPR) of 0.05 and we 
categorized patients as “chronic active” and “non-chronic active” based 
on the total number of rim+lesions per patient by using thresholds ran-
ging from 1 to 6. Each patient’s rim analysis took an average of 300 ms on 
a desktop Intel(R) Core i7-4790 CPU machine at 3.60 GHz and a GeForce 
GTX 1080Ti GPU. The results are shown in Fig. 7. The exact values for 
accuracy and F1 scores can be found in the supplementary materials,  
Table 1. Significant differences between the model and the raters were 
proved only for the 1-rim-lesion threshold when compared to expert #1 
(for the 1 to 6 thresholds, p-values of 0.0034, 0.0604, 0.2284, 0.1770, 
0.1524, 0.1839) and for the 1- and 2-rim-lesions thresholds when com-
pared to expert #2 (p-values of 0.0056, 0.0344, 0.14207, 0.1480, 0.2116, 
0.0961). Based on our patient-level performance analysis and on recent 
evidences from the literature ( Absinta et al., 2019; Maggi, 2020), we 
computed the confusion matrices using the 4-rim + lesions threshold 
(≥4 paramagnetic rim lesions per patient), for both the cross-validation 
and the inter-center scenario (Fig. 8). According to this threshold, 35.4% 
and 22.2% of patients from Basel and Lausanne, respectively, presented 
chronic active MS. 
3.3. Error analysis 
After the first individual screening of the annotation process, 188 
lesions needed consensus review. During the joint session, experts 
agreed to classify 170 as rim+ (90.4%) and 18 as rim- (9.6%). Fig. 9 
shows the ratios of RimNet’s mistakes split by whether the lesions re-
quired consensus in the annotation process or not. Results show how 
RimNet (phase + FLAIR) misclassified significantly (p  <  0.0001) 
more rim+ lesions that required consensus (41.8%) than rim + lesions 
that did not (22.3%). The same behavior was observed with rim- le-
sions, for which RimNet misclassified 38.9% of rim- lesions requiring 
consensus, compared to a miss rate of 4.9% for those lesions with an 
early agreement (p = 0.01). 
Experts re-rated 47 false positive (FP) and 36 false negative (FN) 
lesions corresponding to rim- and rim+ labeled lesions, respectively. 
Inter-rater reliability was measured with the kappa coefficient, which 
was 0.36 and 0.68 for FN and FP lesions, respectively. Twenty-two FP 
(46.8%) were considered mistakes of the automatic rim- lesion selection 
and two FN (5.5%) lesions had segmentation issues. Based on the 
RimNet assessment, experts changed the ground truth decision for 14 
rim- lesions (29.8% of FP cases) and 4 rim+ lesions (11.1% of FN 
cases). Therefore, experts confirmed their initial decision for 11 FP 
(23.4%) and 29 FN (80.5%) lesions. 
Three hundred and eighty-nine rim+ and 4605 rim- lesions were 
classified in terms of their anatomical location within the brain. Most 
rim+ lesions were located in the periventricular white matter 
Fig. 6. ROC and PR curves of RimNet in the inter-center study. Results are compared to those of RimNet trained with data from both centers and evaluated in 
Lausanne (P = 0.47). Abbreviations: ROC, receiver operating characteristic; PR, precision-recall; ICS, inter-center study; RimNet, the proposed multimodal network. 
Table 3 
Lesion-wise results of best single and bimodal architectures, compared to both experts, for the cross-validation and the inter-center scenarios. Abbreviations: PPV, 
positive predictive value; NPV, negative predictive value; P’s (#1), p-values relative to expert #1; P’s (#2), p-values relative to expert #2.           
Lesion-wise results Accuracy F1 Sensitivity Specificity PPV NPV P’s (#1) P’s (#2)  
Cross-validation evaluation 
Single phase model  91.3  57.6  62.1  95.0  53.9  96.3   < 0.0001   < 0.0001 
RimNet: phase + FLAIR  94.6  63.0  70.6  94.9  56.9  97.1   < 0.0001   < 0.0001 
Expert #1  97.9  86.4  77.9  99.8  97.0  97.9   1.000 
Expert #2  97.8  85.6  77.5  99.7  96.5  97.9  1.000  
Inter-center study 
RimNet: phase + FLAIR  93.8  62.3  75.8  95.1  52.8  98.3   < 0.0001   < 0.0001 
Expert #1  98.7  89.6  83.9  99.8  96.2  98.8   0.61 
Expert #2  98.1  84.7  77.9  99.6  92.8  98.4  0.61  
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Fig. 7. Patient-wise analysis depending on the number of paramagnetic rim lesions set to consider a patient as “chronic active.” RimNet (with phase and FLAIR as 
inputs) is evaluated choosing an FPR of 0.05. In the first column, comparison with individual expert performance. In the middle and right columns, absolute values 
for missed and correct predictions showing the comparison between RimNet and the experts’ assessment. 
Fig. 8. Confusion matrices of RimNet (phase + FLAIR) compared to those of the experts. A) shows the results of RimNet trained with cross-validation using all the 
data. B) shows the results of the inter-center study, in which the model is trained with Basel data and evaluated as an ensemble of classifiers with patients from 
Lausanne. 
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(p  <  0.0001, computed with the one-tailed two-proportion z-test). 
Results in Fig. 10 show: 65 (16.7%) rim+ and 981 (21.3%) rim- lesions 
were near the cortex (juxtacortical), 225 (57.8%) rim+ and 1203 
(26.1%) rim- lesions were within the periventricular white matter, and 
99 (25.4%) rim+ and 2215 (48.1%) rim- lesions were in the rest of 
white matter. The deep gray matter, the cerebellum and the brain stem 
regions only included a total of 43 (0.9%), 60 (1.3%), and 103 (2.2%) 
rim- lesions, respectively, and none of them included rim+ lesions. The 
error analysis yielded accuracy and F1 values of 96.3% and 61.2% for 
deep white matter lesions, 92.8% and 53.4% for juxtacortical lesions 
and 88.7% and 67.2% for periventricular lesions, respectively. Positive 
predictive values reported were 55.8%, 44.8%, and 61.7% for deep 
white matter, juxtacortical and periventricular lesions, respectively. 
RimNet only missed one rim- lesion outside these three areas. 
4. Discussion 
Here we propose “RimNet,” a deep-learning prototype for automatic 
assessment of paramagnetic rim lesions in MS. By exploiting different 
MRI contrasts in a multi-center and multi-scanner setting, we showed 
that RimNet performance is at the level of expert readers. Importantly, 
the proposed RimNet prototype achieves remarkably good para-
magnetic rim lesion detection results even when tested in a multi-center 
scenario, thus supporting its potential for generalization across 
different clinical centers and datasets. 
Among the different MRI techniques so far proposed to detect 
paramagnetic rim lesions in MS (Haacke et al., 2009; Yao et al., 2012; 
Walsh et al., 2013; Absinta et al., 2018; Clarke et al., 2020), 3D-EPI 
derived unwrapped phase images adopted in this study have shown 
promising performance in depicting the phase shifts produced by iron- 
laden macrophages and relative myelin content at the lesion edge and 
have been implemented for visual rim+/- analysis in clinical MRI 
studies (Absinta et al., 2018; Absinta et al., 2019). Our automated rim 
evaluation is in line with these findings, as illustrated in our experi-
ments on the single modality network, which showed the best perfor-
mance when using phase as input modality (AUC = 0.913). Although 
containing susceptibility and morphological information of MS lesions, 
T2*-magnitude did not prove as reliable as phase in the manual 
rim + classification (Bian et al., 2013; Absinta et al., 2018). However, 
the T2* network (AUC = 0.901) showed a surprisingly good perfor-
mance, closer than expected to the phase one (p = 0.470). Nowadays, 
the role of FLAIR images during visual rim assessment is mainly re-
stricted to the detection of MS lesions, thus allowing the experts to 
discard potential false positives due to rim-shaped artefacts. Although 
one could expect poor performance using only FLAIR as input, our 
experiments show, on the contrary, that FLAIR’s prediction capabilities 
are far from insignificant (AUC = 0.855). This relatively good perfor-
mance of unimodal FLAIR architecture, along with the notably good 
performance of T2*, suggests that, beyond the presence or absence of a 
lesion, morphometric features such as size, shape, and signal intensity, 
as depicted by these modalities, could play an important role in the 
classification of rim+/- lesions. 
As an improvement on the simple unimodal approaches, we present 
the prototype RimNet, which relies on 3D multimodal MRI input pat-
ches. The early fusion of low-level features extracted from FLAIR and 
phase allows RimNet to extract low-level multimodal and lesion-aware 
features from the latter. Simultaneously and thanks to the straightfor-
ward parallel flow of the data of both modalities, the network benefits 
from the prediction capacities of both contrasts. High-level multimodal 
capabilities are exploited through the last fully connected layers. 
Results showed the superior performance of RimNet over all unimodal 
architectures (AUC = 0.946). When replacing phase with T2*, perfor-
mance dropped significantly (AUC = 0.926), thus validating the hy-
pothesis that T2* is not as reliable as phase regarding the extraction of 
rim + features. Also, the almost negligible loss of performance when 
replacing FLAIR with T2* (AUC = 0.943) supports the hypothesis that 
both FLAIR and T2* can be equally used to extract morphometric fea-
tures that enhance the overall classification performance. This conclu-
sion suggests the feasibility of performing rim+/- analysis with only 
one single MRI acquisition, although we chose to use the conventional 
FLAIR images in most of the analyses in the current work. 
In the lesion-wise analysis, RimNet showed excellent performance 
with regard to sensitivity (70.6%) and negative predictive value (NPV, 
96.3%), which are values close to those of the experts (77.7% and 
97.9%, averaged values for experts’ sensitivity and NPV values, 
Fig. 9. RimNet errors analysis. The proportion of RimNet correct rim+/- pre-
dictions based on whether a consensus was required after the individual ex-
perts’ annotations (consensus needed, bottom row) or not (agreed, top row) is 
shown. The columns split lesions based on their ground truth label (rim+ and 
rim- for the presence or absence of a paramagnetic rim, respectively). The total 
number of lesions of each type is shown inside the pie charts. 
Fig. 10. Anatomical distribution of lesions based on the presence or absence of the paramagnetic rim (rim+ and rim-, respectively). Four regions of interest where 
considered in this analysis: periventricular, juxtacortical, deep white matter and others (cerebellum, brain stem and deep gray matter). The total number of lesions of 
each type is shown inside the pie charts. 
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respectively). The downside of RimNet is its low positive predictive 
value (56.9%, compared to 96.5% and 97% of the experts), which is 
due to a relatively high number of false positives. However, this does 
not prevent it from becoming an excellent assessment tool to assist the 
visual rim analysis, as in this scenario lesions classified as rim+ would 
always be checked by an expert. The biggest obstacle that MRI deep 
learning techniques face in their way toward being included in clinical 
workflows is the need for robustness against changes in the acquisition 
hardware and software. In other words, they must prove a good cap-
ability of generalizing with data acquired in different settings across 
healthcare institutions. The outstanding performance of RimNet in the 
inter-center study (AUC = 0.953) places it as a promising decision 
support tool for physicians in the rim analysis of MS patients, by pro-
viding an accurate rim+ estimation in less than a second. This could be 
integrated with the only requirement of an expert clicking on the lesion 
in order to automatically extract and analyze the patch, instantly ob-
taining the decision of an extra rater. This would help to reduce the 
effect of the interobserver variability and increase the overall accuracy 
in rim analysis. 
The potential of RimNet so conceived is reinforced by the results of 
the RimNet-assessed rating, which was performed in a subset of high- 
confidence RimNet mispredictions. Excluding the lesions that corre-
spond to lesion selection mistakes and therefore would not affect the 
extra-rater scenario, experts changed their initial decision and agreed 
on the existence of a paramagnetic rim for 56% of the re-rated rim- 
lesions. The analysis regarding the anatomical location of the lesions 
can give us a slight intuition on the origin of these mistakes. In the first 
place, the low positive predictive value of RimNet on juxtacortical le-
sions (44.8%), compared to WM (55.8%) or periventricular (67.2%) 
lesions suggests that cortical folds and susceptibility artefacts could 
represent an important source of false positives. Also, the relatively low 
accuracy shown for periventricular lesions (88.7%), mainly due to a 
high number of false positives (8.6%), could have its origin in the lesion 
selection mistakes identified during the RimNet-assessed rating. 
This conception of RimNet is also supported by its results in the 
patient-wise analysis. Considering the recently proposed, clinically 
meaningful threshold of ≥ 4 rim + lesions per patient (Absinta et al., 
2019; Maggi, 2020), RimNet achieves a higher sensitivity (83.5%) and 
negative predictive value (94.0%) than experts (76.3% and 90.5%, re-
spectively, averaged across experts), as well as similar accuracy 
(89.5%) and F1 score (83.5%) (92.3% and 85.8%, respectively, aver-
aged across experts). As already depicted from the lesion-wise analysis, 
the main weaknesses of RimNet are its sensitivity and positive pre-
dictive values. Nonetheless, the absence of a drop in performance in the 
patient-wise inter-center study further supports the potential of RimNet 
as decision-support tool. However, the patient-wise results need to be 
interpreted with caution given the relatively small size of our cohorts 
and the differences in the proportion of patients with ≥ 4 rim + lesions 
across centers (35.4% and 22.2% for Basel and Lausanne, respectively). 
The largest limitation of our method resides in the very nature of 
any patch-based approach: lesions need to fit in patches of a fixed size. 
As a result, big lesions and confluent lesions entail big challenges. In the 
presented approach, the former were fed to the network untouched and 
the latter were manually split into unique lesions. This represents an 
obstacle to full automation of the rim analysis, which is highly needed 
for the inclusion of RimNet in clinical practice. Future work should 
improve our pipeline, so it becomes a fully automated approach. 
Another important limitation of our work resides in the lack of notable 
differences among the acquisition protocols of the scanners included in 
the inter-center study. Thus, although the inter-center study can be 
considered a preliminary analysis of the RimNet generalization power, 
future studies should test the performance of RimNet using data ac-
quired with different gradient-echo MRI sequences. Finally, we only 
focused on FLAIR and T2*-EPI sequences. Future work should explore 
other MRI modalities such as T1-weighted or quantitative susceptibility 
maps (QSM) (Wisnieff et al., 2015; Kaunzner et al., 2019), which could 
provide RimNet with new information on the tissue properties of 
paramagnetic rim lesions. 
In conclusion, RimNet is the first deep learning-based framework to 
automatically classify MS lesions based on the presence/absence of a 
paramagnetic rim. Its excellent performance holds great promise for the 
translation of the paramagnetic rim lesion biomarker in everyday 
clinical practice. 
5. Conflicts of interest and source of funding 
Francesco La Rosa is supported by the European Union's Horizon 
2020 research and innovation program under the Marie Sklodowska- 
Curie project TRABIT (agreement No 765148). 
Hamza Kebiri is supported by the Swiss National Science 
Foundation (SNSF project 205321-182602). 
Po-Jui Lu is supported by the Swiss National Science Foundation 
(SNSF grant grantPP00P3_176984). 
Dr. Matthias Weigel is paid by the Swiss National Science 
Foundation (SNSF grant PP00P3_176984). 
Dr. Mário João Fartaria is full-time employee of Siemens Healthcare 
AG and owns shares in Siemens Healthcare AG. 
Dr. Tobias Kober is full-time employee of Siemens Healthcare AG 
and owns shares in Siemens Healthcare AG. 
Dr. Pascal Sati, Dr. Daniel S. Reich, and Dr. Martina Absinta are 
supported by the Intramural Research Program of the National Institute 
of Neurological Disorders and Stroke, National Institutes of Health, 
Bethesda, Maryland, USA. 
Dr. Martina Absinta is supported by the Conrad N. Hilton 
Foundation (grant# 17313). 
Dr. Cristina Granziera is funded by the Swiss National Science 
Foundation (SNSF) grant PP00P3_176984, the Stiftung zur Förderung 
der gastroenterologischen und allgemeinen klinischen Forschung, 
EUROSTAR E!113682 HORIZON2020. 
For the remaining authors none were declared. 
CRediT authorship contribution statement 
Germán Barquero: Conceptualization, Methodology, Software, 
Validation, Formal analysis, Investigation, Data curation, Writing - 
original draft, Visualization. Francesco La Rosa: Conceptualization, 
Methodology, Software, Validation, Formal analysis, Investigation, 
Data curation, Writing - original draft. Hamza Kebiri: 
Conceptualization, Methodology, Software, Validation, Formal ana-
lysis, Investigation, Data curation, Writing - original draft. Po-Jui Lu: 
Resources, Data curation, Writing - review & editing. Reza 
Rahmanzadeh: Resources, Writing - review & editing. Matthias 
Weigel: Resources, Writing - review & editing. Mário João Fartaria: 
Investigation, Writing - review & editing. Tobias Kober: Investigation, 
Writing - review & editing. Marie Théaudin: Resources, Writing - re-
view & editing. Renaud Du Pasquier: Resources, Writing - review & 
editing. Pascal Sati: Validation, Formal analysis, Investigation, Writing 
- review & editing. Daniel S. Reich: Validation, Formal analysis, 
Investigation, Writing - review & editing. Martina Absinta: Validation, 
Formal analysis, Investigation, Resources, Data curation, Writing - re-
view & editing. Cristina Granziera: Conceptualization, Methodology, 
Validation, Investigation, Resources, Writing - original draft, Writing - 
review & editing, Supervision, Project administration, Funding acqui-
sition. Pietro Maggi: Conceptualization, Methodology, Validation, 
Investigation, Resources, Data curation, Writing - original draft, Writing 
- review & editing, Supervision, Project administration. Meritxell Bach 
Cuadra: Conceptualization, Methodology, Validation, Investigation, 
Resources, Writing - original draft, Writing - review & editing, 
Supervision, Project administration, Funding acquisition. 
G. Barquero, et al.   NeuroImage: Clinical 28 (2020) 102412
10
Acknowledgements 
This work is supported by the Centre d’Imagerie BioMedicale 
(CIBM) of the University of Lausanne (UNIL), the Swiss Federal Institute 
of Technology Lausanne (EPFL), the University of Geneva (UniGe), the 
Centre Hospitalier Universitaire Vaudois (CHUV), the Hôpitaux 
Universitaires de Genève (HUG), and the Leenaards and Jeantet 
Foundations. 
Appendix A. Supplementary data 
Supplementary data to this article can be found online at https:// 
doi.org/10.1016/j.nicl.2020.102412. 
References 
Absinta, M., Sati, P., Fechner, A., Schindler, M.K., Nair, G., Reich, D.S., 2018. 
Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI. AJNR Am. J. 
Neuroradiol. 39 (7), 1233–1238. https://doi.org/10.3174/ajnr.A5660. 
Absinta, M., Sati, P., Gaitán, M.I., Maggi, P., Cortese, I.C.M., Filippi, M., Reich, D.S., 2013. 
Seven-Tesla Phase Imaging of Acute Multiple Sclerosis Lesions: A New Window into 
the Inflammatory Process. Ann. Neurol. 74 (5), 669–678. https://doi.org/10.1002/ 
ana.23959. 
Absinta, M., Sati, P., Masuzzo, F., Nair, G., Sethi, V., Kolb, H., Ohayon, J., Tianxia, W.u., 
Cortese, I.C.M., Reich, D.S., 2019. Association of chronic active multiple sclerosis 
lesions with disability in vivo. JAMA Neurol. https://doi.org/10.1001/jamaneurol. 
2019.2399. 
Absinta, M., Sati, P., Schindler, M., Leibovitch, E.C., Ohayon, J., Tianxia, W.u., Meani, A., 
et al., 2016. Persistent 7-Tesla Phase Rim Predicts Poor Outcome in New Multiple 
Sclerosis Patient Lesions. J. Clin. Investig. 126 (7), 2597–2609. https://doi.org/10. 
1172/JCI86198. 
Bagnato, F., Hametner, S., Yao, B., van Gelderen, P., Merkle, H., Cantor, F.K., Lassmann, 
H., Duyn, J.H., 2011. Tracking Iron in Multiple Sclerosis: A Combined Imaging and 
Histopathological Study at 7 Tesla. Brain 134 (12), 3602–3615. https://doi.org/10. 
1093/brain/awr278. 
Battaglini, M., Jenkinson, M., De Stefano, N., 2012. Evaluating and Reducing the Impact 
of White Matter Lesions on Brain Volume Measurements. Hum. Brain Mapp. 33 (9), 
2062–2071. https://doi.org/10.1002/hbm.21344. 
Bian, W., Harter, K., Hammond-Rosenbluth, K.E., Lupo, J.M., Duan, X.u., Kelley, D.AC., 
Vigneron, D.B., Nelson, S.J., Pelletier, D., 2013. A Serial in Vivo 7T Magnetic 
Resonance Phase Imaging Study of White Matter Lesions in Multiple Sclerosis. 
Multiple Sclerosis Journal 19 (1), 69–75. https://doi.org/10.1177/ 
1352458512447870. 
Chagla, G.H., Busse, R.F., Sydnor, R., Rowley, H.A., Turski, P.A., 2008. Three- 
Dimensional Fluid Attenuated Inversion Recovery Imaging With Isotropic Resolution 
and Nonselective Adiabatic Inversion Provides Improved Three-Dimensional 
Visualization and Cerebrospinal Fluid Suppression Compared to Two-Dimensional 
Flair at 3 Tesla. Invest. Radiol. 43 (8), 547–551. https://doi.org/10.1097/RLI. 
0b013e3181814d28. 
Chavhan, G.B., Babyn, P.S., Thomas, B., Shroff, M.M., Mark Haacke, E., 2009. Principles, 
Techniques, and Applications of T2*-Based MR Imaging and Its Special Applications. 
RadioGraphics 29 (5), 1433–1449. https://doi.org/10.1148/rg.295095034. 
Clarke, M.A., Pareto, D., Pessini-Ferreira, L., Arrambide, G., Alberich, M., Crescenzo, F., 
Cappelle, S., et al., 2020. Value of 3T Susceptibility-Weighted Imaging in the 
Diagnosis of Multiple Sclerosis. Am. J. Neuroradiol.. https://doi.org/10.3174/ajnr. 
A6547. 
Dal-Bianco, A., Grabner, G., Kronnerwetter, C., Weber, M., Höftberger, R., Berger, T., 
Auff, E., et al., 2017. Slow Expansion of Multiple Sclerosis Iron Rim Lesions: 
Pathology and 7 T Magnetic Resonance Imaging. Acta Neuropathol. 133 (1), 25–42. 
https://doi.org/10.1007/s00401-016-1636-z. 
DeLong, E.R., DeLong, D.M., Clarke-Pearson, D.L., 1988. Comparing the Areas under Two 
or More Correlated Receiver Operating Characteristic Curves: A Nonparametric 
Approach. Biometrics 44 (3), 837–845. https://doi.org/10.2307/2531595. 
Filippi, M., Preziosa, P., Rocca, M.A., 2019. Brain Mapping in Multiple Sclerosis: Lessons 
Learned about the Human Brain. NeuroImage, Mapping diseased brains 190 (April), 
32–45. https://doi.org/10.1016/j.neuroimage.2017.09.021. 
Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, 
A., et al., 2002. Whole Brain Segmentation: Automated Labeling of Neuroanatomical 
Structures in the Human Brain. Neuron 33 (3), 341–355. https://doi.org/10.1016/ 
S0896-6273(02)00569-X. 
Fujimoto, K., Polimeni, J.R., van der Kouwe, A.J.W., Reuter, M., Kober, T., Benner, T., 
Fischl, B., Wald, L.L., 2014. Quantitative Comparison of Cortical Surface 
Reconstructions from MP2RAGE and Multi-Echo MPRAGE Data at 3 and 7 T. 
NeuroImage 90 (April), 60–73. https://doi.org/10.1016/j.neuroimage.2013.12.012. 
Glorot, Xavier, and Yoshua Bengio. 2010. “Understanding the Difficulty of Training Deep 
Feedforward Neural Networks,” 8. 
Haacke, E.M., Makki, M., Ge, Y., Maheshwari, M., Sehgal, V., Jiani, H.u., Selvan, M., 
et al., 2009. Characterizing Iron Deposition in Multiple Sclerosis Lesions Using 
Susceptibility Weighted Imaging. J. Magnetic Resonance Imaging: JMRI 29 (3), 
537–544. https://doi.org/10.1002/jmri.21676. 
Hagemeier, J., Heininen-Brown, M., Poloni, G.U., Bergsland, N., Magnano, C.R., Durfee, 
J., Kennedy, C., et al., 2012. Iron deposition in multiple sclerosis lesions measured by 
susceptibility-weighted imaging filtered phase: a case control study. J. Magn. Reson. 
Imaging 36 (1), 73–83. https://doi.org/10.1002/jmri.23603. 
Hammond, K.E., Metcalf, M., Carvajal, L., Okuda, D.T., Srinivasan, R., Vigneron, D., 
Nelson, S.J., Pelletier, D., 2008. Quantitative in Vivo Magnetic Resonance Imaging of 
Multiple Sclerosis at 7 Tesla with Sensitivity to Iron. Ann. Neurol. 64 (6), 707–713. 
https://doi.org/10.1002/ana.21582. 
Harrison, D.M., Li, X., Liu, H., Jones, C.K., Caffo, B., Calabresi, P.A., van Zijl, P., 2016. 
Lesion Heterogeneity on High-Field Susceptibility MRI Is Associated with Multiple 
Sclerosis Severity. Am. J. Neuroradiol. 37 (8), 1447–1453. https://doi.org/10.3174/ 
ajnr.A4726. 
Jehna, M., Pirpamer, L., Khalil, M., Fuchs, S., Ropele, S., Langkammer, C., Pichler, A., 
et al., 2015. Periventricular Lesions Correlate with Cortical Thinning in Multiple 
Sclerosis. Ann. Neurol. 78 (4), 530–539. https://doi.org/10.1002/ana.24461. 
Kaunzner, Ulrike W., Yeona Kang, Shun Zhang, Eric Morris, Yihao Yao, Sneha Pandya, 
Sandra M. Hurtado Rua, et al. 2019. “Quantitative Susceptibility Mapping Identifies 
Inflammation in a Subset of Chronic Multiple Sclerosis Lesions.” Brain 142 (1): 
133–45. https://doi.org/10.1093/brain/awy296. 
Kingma, Diederik P., and Jimmy Ba. 2017. “Adam: A Method for Stochastic Optimization. 
” ArXiv:1412.6980 [Cs], January. http://arxiv.org/abs/1412.6980. 
J.F. Kurtzke, 1983. “Rating Neurologic Impairment in Multiple Sclerosis: An Expanded 
Disability Status Scale (EDSS).” Neurology 33 (11): 1444–1444. https://doi.org/10. 
1212/WNL.33.11.1444. 
La Rosa, Francesco, Ahmed Abdulkadir, Mário João Fartaria, Reza Rahmanzadeh, Po-Jui 
Lu, Riccardo Galbusera, Muhamed Barakovic, Jean-Philippe Thiran, Cristina 
Granziera, and Merixtell Bach Cuadra. 2020. “Multiple Sclerosis Cortical and WM 
Lesion Segmentation at 3T MRI: A Deep Learning Method Based on FLAIR and 
MP2RAGE.” NeuroImage: Clinical 27 (January): 102335. https://doi.org/10.1016/j. 
nicl.2020.102335. 
Le, Minh Hung, Chen, Jingyu, Wang, Liang, Wang, Zhiwei, Liu, Wenyu, Cheng, Kwang- 
Ting Tim, Yang, Xin, 2017. Automated Diagnosis of Prostate Cancer in Multi- 
Parametric MRI Based on Multimodal Convolutional Neural Networks. Phys. Med. 
Biol. 62 (16), 6497–6514. https://doi.org/10.1088/1361-6560/aa7731. 
Maggi, Pietro, et al., 2020. Paramagnetic Rim Lesions are Specific to Multiple Sclerosis: 
An International Multicenter 3T MRI Study. Annals of Neurology. https://doi.org/10. 
1002/ana.25877. In this issue. 
Maggi, Pietro, Fartaria, Mário João, Jorge, João, La Rosa, Francesco, Absinta, Martina, 
Sati, Pascal, Meuli, Reto, et al., 2020. CVSnet: A Machine Learning Approach for 
Automated Central Vein Sign Assessment in Multiple Sclerosis. NMR Biomed. 33 (5), 
e4283. https://doi.org/10.1002/nbm.4283. 
Marques, José P., Kober, Tobias, Krueger, Gunnar, van der Zwaag, Wietske, Van de 
Moortele, Pierre-François, Gruetter, Rolf, 2010. MP2RAGE, a Self Bias-Field 
Corrected Sequence for Improved Segmentation and T1-Mapping at High Field. 
NeuroImage 49 (2), 1271–1281. https://doi.org/10.1016/j.neuroimage.2009.10. 
002. 
Marstal, Kasper, Berendsen, Floris, Staring, Marius, Klein, Stefan, 2016. SimpleElastix: A 
User-Friendly, Multi-Lingual Library for Medical Image Registration. In: In 2016 IEEE 
Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), pp. 
574–582. https://doi.org/10.1109/CVPRW.2016.78. 
Mattes, David, David R. Haynor, Hubert Vesselle, Thomas K. Lewellyn, and William 
Eubank. 2001. “Nonrigid Multimodality Image Registration.” In Medical Imaging 
2001: Image Processing, 4322:1609–20. International Society for Optics and 
Photonics. https://doi.org/10.1117/12.431046. 
Pitt, David, Boster, Aaron, Pei, Wei, Wohleb, Eric, Jasne, Adam, Zachariah, Cherian R., 
Rammohan, Kottil, Knopp, Michael V., Schmalbrock, Petra, 2010. Imaging Cortical 
Lesions in Multiple Sclerosis With Ultra–High-Field Magnetic Resonance Imaging. 
Arch. Neurol. 67 (7), 812–818. https://doi.org/10.1001/archneurol.2010.148. 
Polman, Chris H., Reingold, Stephen C., Banwell, Brenda, Clanet, Michel, Cohen, Jeffrey 
A., Filippi, Massimo, Fujihara, Kazuo, et al., 2011. Diagnostic Criteria for Multiple 
Sclerosis: 2010 Revisions to the McDonald Criteria. Ann. Neurol. 69 (2), 292–302. 
https://doi.org/10.1002/ana.22366. 
Robin, Xavier, Turck, Natacha, Hainard, Alexandre, Tiberti, Natalia, Lisacek, Frédérique, 
Sanchez, Jean-Charles, Müller, Markus, 2011. PROC: An Open-Source Package for R 
and S+ to Analyze and Compare ROC Curves. BMC Bioinf. 12 (March), 77. https:// 
doi.org/10.1186/1471-2105-12-77. 
“R-Project, Version 3.6.2.” n.d. Accessed August 13, 2020. https://cran.r-project.org/bin/ 
windows/base/old/3.6.2/. 
Sati, P., Thomasson, D.M., Li, N., Pham, D.L., Biassou, N.M., Reich, D.S., Butman, J.A., 
2014. Rapid, High-Resolution, Whole-Brain, Susceptibility-Based MRI of Multiple 
Sclerosis. Multiple Sclerosis Journal 20 (11), 1464–1470. https://doi.org/10.1177/ 
1352458514525868. 
Simonyan, Karen, and Andrew Zisserman. 2015. “Very Deep Convolutional Networks for 
Large-Scale Image Recognition.” ArXiv:1409.1556 [Cs], April. http://arxiv.org/abs/ 
1409.1556. 
Viera, Anthony J., Garrett, Joanne M., 2005. Understanding Interobserver Agreement: 
The Kappa Statistic. Fam. Med. 37 (5), 360–363. 
Walsh, Andrew J., Marc Lebel, R., Eissa, Amir, Blevins, Gregg, Catz, Ingrid, Jian-Qiang, 
Lu., Resch, Lothar, et al., 2013. Multiple Sclerosis: Validation of MR Imaging for 
Quantification and Detection of Iron. Radiology 267 (2), 531–542. https://doi.org/ 
10.1148/radiol.12120863. 
Wisnieff, Cynthia, Ramanan, Sriram, Olesik, John, Gauthier, Susan, Wang, Yi, Pitt, David, 
2015. Quantitative Susceptibility Mapping (QSM) of White Matter Multiple Sclerosis 
Lesions: Interpreting Positive Susceptibility and the Presence of Iron. Magn. Reson. 
Med. 74 (2), 564–570. https://doi.org/10.1002/mrm.25420. 
Yao, Bing, Bagnato, Francesca, Matsuura, Eiji, Merkle, Hellmut, van Gelderen, Peter, 
Cantor, Fredric K., Duyn, Jeff H., 2012. Chronic Multiple Sclerosis Lesions: 
Characterization with High-Field-Strength MR Imaging. Radiology 262 (1), 206–215. 
https://doi.org/10.1148/radiol.11110601.  
G. Barquero, et al.   NeuroImage: Clinical 28 (2020) 102412
11
